Swiss National Bank raised its position in Cardiovascular Systems, Inc. (NASDAQ:CSII – Get Rating) by 8.1% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 95,800 shares of the medical device company's stock after purchasing an additional 7,200 shares during the quarter. Swiss National Bank owned 0.24% of Cardiovascular Systems worth $2,165,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also modified their holdings of the company. Acadian Asset Management LLC lifted its stake in Cardiovascular Systems by 294.7% during the 4th quarter. Acadian Asset Management LLC now owns 2,684 shares of the medical device company's stock worth $50,000 after acquiring an additional 2,004 shares in the last quarter. Signaturefd LLC increased its stake in Cardiovascular Systems by 8,110.3% during the first quarter. Signaturefd LLC now owns 2,381 shares of the medical device company's stock worth $54,000 after purchasing an additional 2,352 shares during the period. Point72 Hong Kong Ltd acquired a new stake in shares of Cardiovascular Systems during the fourth quarter worth about $74,000. Nisa Investment Advisors LLC boosted its stake in shares of Cardiovascular Systems by 54.3% in the first quarter. Nisa Investment Advisors LLC now owns 3,495 shares of the medical device company's stock valued at $79,000 after purchasing an additional 1,230 shares during the period. Finally, Simplex Trading LLC grew its holdings in shares of Cardiovascular Systems by 35.3% in the first quarter. Simplex Trading LLC now owns 9,971 shares of the medical device company's stock valued at $225,000 after purchasing an additional 2,602 shares in the last quarter. 91.72% of the stock is currently owned by hedge funds and other institutional investors.
Get
Cardiovascular Systems alerts:
Cardiovascular Systems Price Performance
Cardiovascular Systems stock opened at $13.21 on Thursday. The company has a quick ratio of 5.19, a current ratio of 6.05 and a debt-to-equity ratio of 0.08. Cardiovascular Systems, Inc. has a 52-week low of $13.21 and a 52-week high of $37.58. The firm has a market cap of $541.15 million, a PE ratio of -13.92 and a beta of 0.94. The company's 50 day moving average is $15.34 and its two-hundred day moving average is $17.53.
Cardiovascular Systems Profile
(Get Rating)
Cardiovascular Systems, Inc, a medical device company, develops and commercializes solutions to treat peripheral and coronary artery diseases in the United States and internationally. The company offers peripheral artery disease products, which are catheter-based platforms to treat various plaque types in above and below the knee, including calcified plaque, as well as address various limitations related with surgical, catheter, and pharmacological treatment alternatives; and peripheral support products.
Featured Stories
- Get a free copy of the StockNews.com research report on Cardiovascular Systems (CSII)
- Can Alibaba And Baidu Finally Rally With Delisting Fears Gone?
- Is World Wresting Entertainment Getting Ready to Be Sold?
- 3 Materials Stocks That May Earn a Place on Your Watchlist
- Crowdstrike Stock Retraces, As Earnings Sober Expectations
- Will The Institutions Buy The Dip In Ambarella Stock?
Receive News & Ratings for Cardiovascular Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiovascular Systems and related companies with MarketBeat.com's FREE daily email newsletter.
